The tumor microenvironment influences both therapeutic outcome and malignant progression. Previous studies from my laboratory have indicated that hypoxia induces apoptosis in oncogenically transformed cells in vitro, can act as a selective pressure for the expansion of transformed cells possessing diminished apoptotic potential, and co-localizes with apoptotic regions in tumors. The tumor suppressor protein p53 induces rapid apoptosis in response to oxygen concentrations that induce an S-phase arrest. Hypoxia-induced p53 is nuclear and associates with p53-response elements in target genes, such as mdm2 and p21. The cellular decision to use p53 transactivation or transrepression is mediated after the binding of p53 to the promoter by the stress, and is determined by the presence of co-activators or co-repressors. In contrast to p53-induced by DNAdamaging agents, hypoxia-induced p53 has primarily transrepression activity. Using extensive microarray analysis, we identified families of repressed targets of p53 that are involved in cell signaling, DNA repair, cell-cycle control and differentiation. Mutation analysis has determined that loss of transrepressor activity of p53 results in diminished apoptosis under hypoxic conditions. Mutation of residues 25,26 or 53,54 in the amino terminus of p53, that have previously been shown to inactivate p53-dependent transactivation, could still signal apoptosis under hypoxic conditions. However, mutation of all four residues completely abolished p53 dependent apoptosis as well as p53 dependent transrepression. This study defines a new role for the 53,54 residues of p53 regulating transrepression and suggests that 25,26 and 53,53 work in the same pathway to induce apoptosis through gene repression. Furthermore, p53 induced by both genotoxic as well as nongenotoxic stress is able to bind to the same promoters, but it is the stress that determines whether apoptosis is mediated by transcriptionally dependent or independent pathways. The critical hypothesis that we will be testing is that genotoxic and non-genotoxic stresses modulate gene activation and repression via p53's association with chromatin. In this proposal, we will demonstrate the importance of gene repression by hypoxia in apoptosis and differentiation using in vivo derived models. We will investigate the importance of protein interactions with the amino terminus of p53 in regulating gene repression by hypoxia. We will test these hypotheses through a combination of genetic and biochemical approaches in cell lines and in mice.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA088480-10
Application #
7649387
Study Section
Radiation Therapeutics and Biology Study Section (RTB)
Program Officer
Spalholz, Barbara A
Project Start
2000-07-01
Project End
2010-04-30
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
10
Fiscal Year
2009
Total Cost
$314,678
Indirect Cost
Name
Stanford University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
LaGory, Edward L; Wu, Colleen; Taniguchi, Cullen M et al. (2015) Suppression of PGC-1? Is Critical for Reprogramming Oxidative Metabolism in Renal Cell Carcinoma. Cell Rep 12:116-127
Kariolis, Mihalis S; Miao, Yu Rebecca; Jones 2nd, Douglas S et al. (2014) An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis. Nat Chem Biol 10:977-83
Rankin, Erinn B; Fuh, Katherine C; Castellini, Laura et al. (2014) Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET. Proc Natl Acad Sci U S A 111:13373-8
Taniguchi, Cullen M; Miao, Yu Rebecca; Diep, Anh N et al. (2014) PHD inhibition mitigates and protects against radiation-induced gastrointestinal toxicity via HIF2. Sci Transl Med 6:236ra64
Razorenova, Olga V; Castellini, Laura; Colavitti, Renata et al. (2014) The apoptosis repressor with a CARD domain (ARC) gene is a direct hypoxia-inducible factor 1 target gene and promotes survival and proliferation of VHL-deficient renal cancer cells. Mol Cell Biol 34:739-51
Giaccia, Amato J (2014) Molecular radiobiology: the state of the art. J Clin Oncol 32:2871-8
Taniguchi, Cullen M; Finger, Elizabeth C; Krieg, Adam J et al. (2013) Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes. Nat Med 19:1325-30
Rankin, Erinn B; Wu, Colleen; Khatri, Richa et al. (2012) The HIF signaling pathway in osteoblasts directly modulates erythropoiesis through the production of EPO. Cell 149:63-74
Welford, Scott M; Giaccia, Amato J (2011) Hypoxia and senescence: the impact of oxygenation on tumor suppression. Mol Cancer Res 9:538-44
Chan, Denise A; Giaccia, Amato J (2011) Harnessing synthetic lethal interactions in anticancer drug discovery. Nat Rev Drug Discov 10:351-64

Showing the most recent 10 out of 33 publications